Lunai Bioworks (LNAI) Operating Income (2011 - 2026)

Lunai Bioworks' Operating Income history runs 15 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• In Q1 2026, Operating Income rose 64.51% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$133.5 million (down 68.7% YoY), while the FY2025 annual figure was -$189.0 million, down 131.46% from the prior year.
• Operating Income was -$1.5 million for Q1 2026 at Lunai Bioworks, up from -$1.8 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$1.5 million in Q1 2026 to a low of -$126.9 million in Q2 2025.
• Historically, Operating Income has averaged -$24.6 million across 5 years, with a median of -$4.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Operating Income sank 1164.47% in 2024, then soared 93.8% in 2025.
• A 5-year view of Operating Income shows it stood at -$4.4 million in 2022, then climbed by 2.24% to -$4.3 million in 2023, then fell by 6.47% to -$4.5 million in 2024, then jumped by 59.89% to -$1.8 million in 2025, then grew by 18.98% to -$1.5 million in 2026.
• The last three Operating Income figures came in at -$1.5 million (Q1 2026), -$1.8 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.